EUVIMEDEUVIMED entdecken
Crossref

Calotropis procera: from ethnomedicine to modern therapeutics- phytochemistry, pharmacology, toxicity, and patent perspectives

Ravindra G. Mali, Kalpesh Yeole, Chaitali Pardeshi, Raju Wadekar

The Journal of Phytopharmacology · 27.04.2026 · 15 (2) · 181-191

DOI: 10.31254/phyto.2026.15209 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Phytopharmacology, online erschienen am 27.04.2026. Verfasst von Ravindra G. Mali und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

C. procera (Aiton) W.T. Aiton is a widely distributed xerophytic medicinal shrub inhabiting arid and semi-arid parts of Asia and Africa, and is widely used in indigenous systems of medicine to manage several pathological conditions. This review consolidates the available literature in relation to its ethnobotanical significance, phytochemistry and pharmacological activities in an endeavour to facilitate future scientific investigation. Ethnomedicinal reports describe its utilisation for the management of a vast array of conditions, including inflammation, diseases of the skin, respiratory tract and digestive system, as well as infestation by different kinds of parasites across diverse ethnic systems. Chromatographic analysis shows the presence of biologically active compounds like cardenolides (calotropin, uscharin, etc.), flavonoids, terpenoids, alkaloids, phenolic compounds, etc., which attribute its biological properties. Pharmacological activities evaluated so far, both in vitro and in vivo, have proved significant anti-inflammatory, antioxidant, antibacterial, antifungal, antitumor and antiparasitic as well as anti-diabetic and hepatoprotective actions which occur through different pathways such as inhibition of pro-inflammatory mediators, alleviation of oxidative stress and induction of apoptosis, etc. But toxic cardiac glycosides present in it make strict dose standardization a prerequisite. Clinical trials remain lacking, though enough pre-clinical evidence is available; therefore, further research work with standardised materials of C. procera, safety evaluation and clinical trials will be fruitful. It may prove to be an important source for drug discovery in phytomedicine.

Zitieren

APA

Mali, R. G., Yeole, K., Pardeshi, C., & Wadekar, R. (2026). Calotropis procera: from ethnomedicine to modern therapeutics- phytochemistry, pharmacology, toxicity, and patent perspectives. The Journal of Phytopharmacology, 15(2), 181-191. https://doi.org/10.31254/phyto.2026.15209

Vancouver

Mali RG, Yeole K, Pardeshi C, Wadekar R. Calotropis procera: from ethnomedicine to modern therapeutics- phytochemistry, pharmacology, toxicity, and patent perspectives. The Journal of Phytopharmacology. 2026;15(2):181-191. doi:10.31254/phyto.2026.15209

BibTeX
@article{Mali2026,
  author = {Mali, Ravindra G. and Yeole, Kalpesh and Pardeshi, Chaitali and Wadekar, Raju},
  title = {Calotropis procera: from ethnomedicine to modern therapeutics- phytochemistry, pharmacology, toxicity, and patent perspectives},
  journal = {The Journal of Phytopharmacology},
  year = {2026},
  volume = {15},
  number = {2},
  pages = {181--191},
  doi = {10.31254/phyto.2026.15209}
}
Kostenlos starten →